www.linkedin.com/posts/mattkr...

I post a survey about what kinda curry you may like... and BOOM. Thing explodes. LOL

Here's the link [LinkedIn]: www.linkedin.com/feed/update/...

🚨 New contender in the oral GLP-1 race 🚨

www.linkedin.com/posts/mattkr... (OPEN ACCESS)

Ascletis Pharma Inc. ($1672.HK) just dropped early PIb data showing up to 6.5% placebo-adjusted weight loss in obese patients after 4 weeks on ASC30.

By @biocentury.bsky.social's @stephenhansen.bsky.social

“Hey you guys!” – The Goonies

Looking for a roadmap for how to handle Tariffs?

BioCentury Inc.'s Simone Fishburn breaks down things you need to know in her latest report:

"Tariffs are here — sweating the SWOT analysis" www.linkedin.com/posts/mattkr...

PERSONAL NOTE: 🌱 Need a break from doom-scrolling? Planting and prompting been working for me! 💻

- 2 things that help me stay grounded (literally and digitally):

www.linkedin.com/posts/mattkr...

Chasing Amy? Nah... How about Chasing Amylin?

BioCentury dives into Roche’s $1.7B upfront bet on Zealand Pharma.

🔍 What’s in it for you?

1️⃣ Amylin is shaping up to be the next frontier in obesity drug development
2️⃣ Roche has skin in the game

Details: www.biocentury.com/article/6553...